Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (17 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net sales
56
52
53
76
74
56
64
Cost of goods sold
36
33
34
53
50
37
43
Gross Profit
20
19
18
24
24
19
22
Selling and marketing expenses
9
9
-9
10
11
10
11
Research and development expenses
1
1
-1
1
1
1
1
General and administrative expenses
3
3
-3
4
4
4
4
Corporate expense
13
13
13
16
16
15
16
Operating Income
7
7
5
8
7
4
5
Foreign Currency Gain
0
0
0
0
0
0
0
Interest expense
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
Net non-operating income (expense)
0
0
0
0
0
0
0
Income before income taxes
7
7
5
7
7
4
6
Provision for income taxes - Note 13
2
2
2
2
2
1
2
Income from continuing operations
5
0
0
0
0
0
0
Loss from discontinued operations, net of income tax benefit of $11,000 - Note 13
0
0
0
0
0
0
0
Net income
5
5
4
5
5
3
4
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Dec 27, 2013 n/a
calculated values,
restated on Dec 23, 2014 n/a
calculated values,
restated on Jan 4, 2016 n/a
calculated values,
restated on Jan 4, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (28 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
n/a
1
2
3
5
7
1
Securities available for sale - Note 3
n/a
4
4
0
0
0
0
Accounts receivable, net of allowances
n/a
7
6
8
8
6
8
Inventories - Note 3
n/a
4
8
9
6
7
9
Deferred income taxes - Note 13
n/a
1
0
1
0
0
0
Prepaid expenses
n/a
0
0
0
1
1
0
Total current assets
n/a
17
21
21
21
21
19
Property and equipment, net
n/a
6
5
5
5
5
5
Goodwill
n/a
2
2
5
4
4
4
Intangibles, net
n/a
0
0
4
3
3
2
Other assets - Note 7
n/a
3
2
2
3
3
3
Identifiable assets
n/a
27
31
38
36
36
32
Liabilities and owners' equity
Accounts payable
n/a
2 2335633
3 3233597
3 3360859
3 2658125
2 2477198
4 4035333
Accrued and sundry liabilities - Note 8
n/a
3 2641348
2 2371288
3 3359487
3 2875600
2 2051662
3 3120111
Total current liabilities
n/a
5 4976981
6 5604885
7 6720346
6 5533725
5 4528860
7 7155444
Deferred income taxes - Note 13
n/a
0 196000
0 161000
0 293149
0 194883
0 160685
0 348479
Deferred compensation - Note 11
n/a
1 660618
1 608992
1 554287
1 534239
0 457457
0 375939
Total long-term liabilities
n/a
1 856618
1 769992
1 847436
1 729122
1 618142
1 724418
Total liabilities
n/a
6 5833599
6 6374877
8 7567782
6 6262847
5 5147002
8 7879862
Commitments and contingencies - Notes 19 and 20
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock
n/a
1 870946
1 1111706
3 2757359
3 2626526
3 3064658
0 0
Additional paid-in capital
n/a
1 696491
1 765988
1 838252
1 872494
1 906834
0 0
Retained earnings
n/a
20 19811152
22 22343429
26 26199977
27 26828012
28 27735768
27 26848299
Accumulated other comprehensive loss
n/a
0 0
0 0
0 284396
0 -213251
-1 -1007428
-3 -2546539
Total shareholders' equity
n/a
21 21378589
24 24221123
30 30079984
30 30113781
31 30699832
24 24301760
us-gaap_LiabilitiesAndStockholdersEquity
n/a
27 27212188
31 30596000
38 37647766
36 36376628
36 35846834
32 32181622
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Dec 28, 2012 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net income
5
5
4
5
5
3
4
Depreciation and amortization
1
1
1
1
1
1
1
Amortization
0
0
0
0
1
0
0
Provision for losses on accounts receivable
0
0
0
0
0
0
0
Provision for deferred income taxes
0
0
0
0
0
0
0
Gain on sale and disposal of property and equipment
0
0
0
0
0
0
0
Increase in cash value of life insurance
0
0
0
0
0
0
0
Deferred compensation
0
0
0
0
0
0
0
Stock compensation expense
0
0
0
0
0
0
0
Accounts receivable
2
-1
1
0
0
2
-2
Inventories
0
0
-4
1
3
-1
-2
Prepaid expenses and other assets
0
0
0
0
0
0
0
Accounts payable and accrued and sundry liabilities
0
0
1
0
-1
-1
3
Acquisition of M.C. Healthcare
0
0
0
-8
0
0
0
Purchases of Securities Available for Sale
-4
-2
-3
0
0
0
0
Proceeds from sale of securities available for sale
0
2
2
4
0
0
0
Net cash provided by operating activities
7
4
3
7
8
4
4
Purchases of property and equipment
0
0
0
-1
-1
-1
-1
Proceeds from sale of property and equipment
0
0
0
0
0
0
0
Payments for other assets
0
0
0
0
0
0
0
Net cash used for investing activities
-4
0
-1
-5
-1
-1
-1
Dividends paid
-1
-4
-1
-1
-4
-2
-5
Proceeds from long-term debt
0
0
0
9
0
0
0
Repayment of long-term debt
-1
0
0
-9
0
0
0
Purchase and retirement of common stock
-1
0
0
0
0
0
-4
Proceeds from exercise of options for common stock
0
0
0
0
0
0
0
Net Cash Used for Financing Activities
-2
-4
-1
-1
-5
-1
-9
Effect of exchange rates on cash
0
0
0
0
0
0
0
(Decrease) increase in cash and cash equivalents
0
0
1
1
3
1
-6
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Dec 27, 2013 n/a
calculated values,
restated on Dec 23, 2014 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,